BIOT
Unleashing Women’s Potential in Advanced Therapies
📢 Women in advanced therapies: 'Get comfortable being uncomfortable' and drive change. 💪 Seek out challenging opportunities, take risks, and make a difference! 🌍🚀🌟🙋♀️
Alvotech’s Biosimilar Plant Receives Second FDA Violation
🔬🚨 Alvotech, a biopharmaceutical company, receives another FDA observation at its biosimilar plant, potentially delaying product approval.
Exciting Collaboration Boosts Excellos’ Cell Therapy!
📣 CDMO Excellos teams up with Vitalant for cell therapy advancements! 💉🧪 Excellos' programs will benefit from Vitalant's services, boosting their biotech offerings. 🚀
Oligo Factory MA Plant Gets GMP Greenlight!
🌱 Exciting news! The Oligo Factory MA plant 🏭 has received the GMP greenlight 💚 for biotech industry. Get ready for innovation! 🚀
Game-Changing RNA Vaccine Success: How One Company Perfected Manufacturing
📰 Arcturus Therapeutics, the pioneer in self-amplifying mRNA (saRNA) vaccines, credits perfecting manufacturing techniques for success. 💉🏭🔬
Major Leadership Changes in Oncology Biotechs: What’s Next?
📰 Ins & Outs: C-suite changes across oncology biotechs explores recent leadership transitions in cancer-focused biotech companies. 👥🌟🏥🧪🔬
Breaking: CGTs Accessibility Challenges Uncovered in 2023
📰CGTs in 2023: Floodgates open but patient access still sticky highlights challenges in patient access to CGTs. 👥💡💰⚕️🤝🌍
Lonza shuts down Swiss manufacturing site cutting 190 jobs
📢 Lonza is decommissioning its mammalian manufacturing site in Visp, Switzerland, after 30 years of operation. 🏭✅ This decision is driven by market dynamics and the need for flexibility. ❌ However, Lonza will focus on other sites and genecell therapies. 😔 Around 190 jobs will be lost.
Revolutionary Cancer Treatment Process: Cost-Effective and Scalable!
📢 Researchers at the University of Ottawa have developed an innovative production process for cancer treatments using NK cells and EVs. 🩺 This cost-effective and scalable breakthrough could revolutionize immunotherapies. 🚀🌟
Revolutionary Partnership Boosts Spider Silk Production
🌐 AMSilk GmbH and 21st.BIO AS are partnering to accelerate the production of spider silk-based proteins. 🔬💡👟
